Iowa SF 2157: A bill for an act relating to medical cannabidiol by providing deductions from the individual and corporate income taxes for expenses incurred by medical cannabidiol manufacturers and dispensaries, and exempting the sale of medical cannabidiol products from the sales and use tax, and including retroactive applicability provisions.

Status: Subcommittee: Dawson, Bolkcom, and Goodwin. (as of 2022-02-02)

State: Iowa · Session: 2021-2022 · Bill: SF 2157

Subjects: corporate taxes, drugs, expenditures, income taxes, internal revenue code, manufacturing, marijuana, sales, sales taxes, tax exemptions, taxation, use taxes

Sponsors: Brown

View Iowa SF 2157 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.